Portal Saúde Direta - Busca Palavra

BUSCA POR PALAVRA

POSTAGENS ANTERIORES

TAGS CLOUD

Protocolos/Algoritmos/Diretrizes/Fluxogramas

Advertência: Estes artigos e resumos são protegidos pela Lei de Direitos Autorais (Lei 9.610/98), sendo vedada a sua transcrição sem citação da fonte e a sua reprodução com finalidades comerciais sem autorização dos autores.

É necessário o Adobe Acrobat Reader instalado.

Primary Prevention of Food Allergy in Children and Adults: Systematic Review

de Silva et al.
Allergy 69 (2014) 581-589, 2014
Número: 2903 / Publicado em 11/10/2020 - 13:22

Food allergies can have serious physical, social, and financial consequences. This systematic review examined ways to prevent the development of food allergy in children and adults.

Abrir arquivo em PDF

Revised U.K. Guidelines for the Management of Cutaneous Melanoma 2010

J.R. Mars den, J.A. Newton-Bishop, L. Burrows, M. Cook, P.G. Corrie, N.H. Cox, M.E. Gore, P. Lorigan, R. MacKie, P. Nathan, H. Peach, B. Powell and C. Walker
British Journal of Dermatology 2010 163, pp238–256
Número: 2902 / Publicado em 06/03/2015 - 15:36

These guidelines for the management of cutaneous melanoma present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiology, diagnosis, investigation and follow up.

Abrir arquivo em PDF

Antidrug Antibodies in Psoriasis: a Systematic Review

L. Hsu, B.T. Snodgrass and A.W. Armstrong
British Journal of Dermatology (2014) 170 , pp261–273
Número: 2901 / Publicado em 02/04/2015 - 08:21

Antidrug antibodies (ADAs) against biological agents may be clinically significant and potentially alter a biological drug’s treatment efficacy. This systematic review aims to (i) determine the prevalence of ADAs against infliximab, etanercept, adalimumab and ustekinumab in patients with psoriasis; (ii) ascertain whether ADAs are associated with changes in drug efficacy; and (iii) explore the use of concomitant methotrexate to prevent ADA formation.

Abrir arquivo em PDF

Consenso Bari�trico

Jo�o Batista Marchesini e Irineu Rasera Jr
Sociedade Brasileira de Cirurgia Bari�trica e Metab�lica (SBCBM)
Número: 2900 / Publicado em 11/10/2020 - 13:20

Este consenso entende que os demais procedimentos e t�cnicas cir�rgicas para o controle da obesidade n�o relacionadas neste documento n�o apresentam indica��o atual de utiliza��o ou se encontram em fase de estudos, sem apresentar at� o momento documenta��o cient��fica consistente que permitam sua realiza��o fora de protocolos de pesquisa devidamente regulamentados pelo Conselho Nacional de �tica em Pesquisa (CONEP), em conformidade com a Resolu��o 196 de 1996 do Conselho Nacional de Sa�de ou outra que venha substitu��-la ou complement�-la.

Abrir arquivo em PDF

Acute Coronary Syndromes: Initial Medical Therapy Guideline

Guideline 14.2 - July 2012
Australian Resuscitation Council
Número: 2899 / Publicado em 06/03/2015 - 14:26

There are a number of therapies in patients with Acute Coronary Sydnromes (ACS) that provide relief for symptoms.

Abrir arquivo em PDF

Standards of Medical Care in Diabetes - 2015: Summary of Revisions

American Diabetes Association
Diabetes Care 2015;38 (Suppl. 1)
Número: 2898 / Publicado em 06/03/2015 - 13:58

Whereas the “Standards of Medical Care in Diabetes - 2015” should still be viewed as a single document, it has been divided into 14 sections, each individually referenced, to highlight important topic areas and to facilitate navigation. The supplement now includes an index to help readers find information on particular topics.

Abrir arquivo em PDF

Definition and Diagnosis of Diabetes mellitus and Intermediate Hyperglycemia

International Diabetes Federation
World Health Organization 2006
Número: 2896 / Publicado em 06/03/2015 - 13:44

Recent estimates indicate there were 171 million people in the world with diabetes in the year 2000 and this is projected to increase to 366 million by 2030. Diabetes is a condition primarily defined by the level of hyperglycaemia giving rise to risk of microvascular damage (retinopathy, nephropathy and neuropathy). It is associated with reduced life expectancy, significant morbidity due to specific diabetes related microvascular complications, increased risk of macrovascular complications (ischaemic heart disease, stroke and peripheral vascular disease), and diminished quality of life.

Abrir arquivo em PDF

Preventing Kidney Failure in People with Diabetes

Diabetes UK
Diabetes UK 2013
Número: 2895 / Publicado em 06/03/2015 - 13:35

Diabetes UK aims to improve kidney care for people with diabetes and reduce the number of people requiring renal replacement therapy. Raising awareness of kidney complications in diabetes and of the importance of a kidney risk assessment at the annual review is crucial, both amongst people with diabetes and in all those who are involved in their care. It is also important to make people aware of the services that should be provided and ensure that these are in place in all localities. This position statement includes recommendations for healthcare professionals and professionals to help them make sure they are providing people with diabetes access to the care they need to prevent kidney disease.

Abrir arquivo em PDF

Testosterone Replacement Therapy Guideline

R Khairi, N Shaw, EC Crowne
The British Society for Paediatric Endocrinology and Diabetes
Número: 2894 / Publicado em 06/03/2015 - 13:27

Guideline for use of testosterone replacement therapy for induction of and progression through puberty in hypogonadotrophic hypogonadism (HH), androgen deficiency secondary to testicular disease and in constitutional delay of growth and puberty (CDGP).

Abrir arquivo em PDF

Diabetic Ketoacidosis Calculator

British Society of Paediatric Endocrinology and Diabetes
Pediatric Diabetes 2009: 10 (Suppl. 12): 118-133.
Número: 2893 / Publicado em 11/10/2020 - 13:25

The 2014 NICE Guidelines will indicate that there is insufficient evidence to consider anticoagulant prophylaxis in children with DKA to prevent venous thrombosis, including in young children with central venous lines. Therefore any previous recommendation for anticoagulant prophylaxis has been removed from the current guidelines. No other major changes are anticipated until the full review is complete.

Abrir arquivo em PDF